These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31825131)

  • 1. In vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefazolin, cefovecin, doxycycline and pradofloxacin over a range of bacterial densities.
    Blondeau JM; Fitch SD
    Vet Dermatol; 2020 Jun; 31(3):187-e39. PubMed ID: 31825131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin.
    Blondeau JM; Shebelski SD
    Vet Dermatol; 2016 Aug; 27(4):267-e63. PubMed ID: 27307405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
    Bennie CJ; To JL; Martin PA; Govendir M
    Aust Vet J; 2015; 93(1-2):40-5. PubMed ID: 25622709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats.
    Maaland M; Guardabassi L
    Vet Microbiol; 2011 Aug; 151(3-4):396-9. PubMed ID: 21482044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the comparative minimum inhibitory and mutant prevention concentration values for moxifloxacin and pradofloxacin against canine and human isolates of Staphylococcus pseudintermedius and S. schleiferi.
    Plowgian C; Blondeau JM; Levinson M; Rosenkrantz W
    Vet Dermatol; 2019 Dec; 30(6):481-e142. PubMed ID: 31486554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of cefovecin disk-diffusion test for predicting mecA gene-containing strains of Staphylococcus pseudintermedius and clinical efficacy of cefovecin in dogs with superficial pyoderma.
    Iyori K; Toyoda Y; Ide K; Iwasaki T; Nishifuji K
    Vet Dermatol; 2013 Feb; 24(1):162-7.e35-6. PubMed ID: 23331693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
    Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
    Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole.
    Blondeau JM; Fitch SD
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tract infection caused by methicillin-resistant Staphylococcus pseudintermedius in a dog.
    Rubin JE; Gaunt MC
    Can Vet J; 2011 Feb; 52(2):162-4. PubMed ID: 21532822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of canine methicillin-resistant Staphylococcus pseudintermedius strains to pradofloxacin.
    Kizerwetter-Świda M; Chrobak-Chmiel D; Rzewuska M; Binek M
    J Vet Diagn Invest; 2016 Sep; 28(5):514-8. PubMed ID: 27449131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
    Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
    Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin.
    Shimizu T; Harada K; Kataoka Y
    Acta Vet Scand; 2013 May; 55(1):37. PubMed ID: 23634902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
    Liu X; Boothe DM; Jin Y; Thungrat K
    World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
    Jain JG; Housman ST; Nicolau DP
    J Antimicrob Chemother; 2014 Sep; 69(9):2443-7. PubMed ID: 24827890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Impact of Methicillin-Resistant Staphylococcus pseudintermedius Biofilm Formation on Antimicrobial Susceptibility.
    Walker M; Singh A; Nazarali A; Gibson TW; Rousseau J; Weese JS
    Vet Surg; 2016 Oct; 45(7):968-971. PubMed ID: 27500604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
    Maaland MG; Papich MG; Turnidge J; Guardabassi L
    J Clin Microbiol; 2013 Nov; 51(11):3547-54. PubMed ID: 23966509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius.
    Campbell O; Gagnon J; Rubin JE
    Lett Appl Microbiol; 2019 Nov; 69(5):353-357. PubMed ID: 31508840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of Staphylococcus pseudintermedius susceptibility to common cephalosporins used in dogs.
    Westermeyer RR; Roy AF; Mitchell MS; Merchant SR
    Vet Ther; 2010; 11(3):E1-9. PubMed ID: 20960413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.
    Johnson JR; Kuskowski MA; Owens K; Clabots C; Singer RS
    Vet Microbiol; 2009 Apr; 136(1-2):108-14. PubMed ID: 19019576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.